Pioneering PRECISION with the First Pharmacogenetic Trial in IPF to Move Beyond “One-SizeFits-All” & Optimize Treatment Effectiveness
Time: 11:30 am
day: Day Two Track B AM
Details:
• Exploring the first-ever pharmacogenetic trial for IPF investigating how a specific genetic variant influences response to treatment
• Examining trial design to facilitate patient participation and reflect a real-world clinical setting
• Reviewing the potential to establish a new paradigm for personalized treatment in IPF by tailoring therapy based on individual genetic profile